Monotherapy for Non-small Cell Lung Cancer (NSCLC)Created 3 weeks ago by anniepery
As a monotherapy, ceritinib is used for the first line treatment option of patients with ALK +Ve (Anaplastic lymphoma kinase +Ve) advanced non-small cell lung cancer (NSCLC).
The usual dose of ceritinib is 450mg (3-tablets) taken once in a day with food, although your healthcare professional could modify your usual recommended dose if required. Avoid changing the dose of ceritinib without talking to your healthcare provider. Ceritinib price in India varies from generic version drugs to branded drugs. The ceritinib 150 mg as monotherapy is also used for the treatment of adult patients with anaplastic lymphoma kinase +Ve advanced non-small cell lung cancer (NSCLC) previously treated with the therapy of crizotinib.